1. The new K+ channel opener aprikalim (PR 52891) reduces experimental infarct size in dogs in the absence of hemodynamic changes;Auchampach;J. Pharmacol. Exp. Ther.,1991
2. Haemodynamic and pharmacological mechanisms of the hypotensive effects of cromakalim in rats: blockade by glibenclamide;Cavero;Br. J. Pharmacol.,1988
3. Failure of glibenclamide to protect against ischemic ventricular fibrillation in a canine model of myocardial infarction;Chi;J. Mol. Cell. Cardiol.,1989
4. Actions of pinacidil at a reduced potassium concentration: a direct cardiac effect possibly involving the ATP-dependent potassium channel;Chi;J. Cardiovasc. Pharmacol.,1993
5. Antihypertensive and haemodynamic properties of the potassium channel activating (−) enantiomer of cromakalim in animals models;Clapham;Arzneim.-Forsch.,1991